Novel Liquid Biopsy ML multigene mRNA Expression for Clinical Trials: from Discovery to CDx Development, Upcoming Webinar Hosted by Xtalks

This free webinar will explore the transformative potential of liquid biopsy and multigene mRNA expression assays in clinical trials.

TORONTO, Sept. 11, 2024 /PRNewswire-PRWeb/ -- Liquid biopsy is becoming an attractive matrix to develop non-invasive in-vitro diagnostics for standard patient care and pharmaceutical trials, but multigene mRNA expression has been relatively sidelined. In this webinar, the expert speaker will focus on the impact of multigene mRNA expression assays in clinical trials.

In addition to assays being validated for multiple solid and hematological tumor indications, Wren's lead NETest® and PROSTest® for neuroendocrine tumors (NETs) and prostate cancer are being offered to patients and biopharma companies in a CLIA, CAP and NYS-licensed laboratory.

In this webinar, the expert speaker will demonstrate the key analytical and clinical performance characteristics of assays and demonstrate their clinical validity for different applications such as diagnostic and prognostic biomarkers for patient monitoring and detecting minimal residual disease (MRD) or recurrence and for predicting response to therapeutics.

In addition to these clinical applications, the expert will show a novel approach that can help in target and biomarker discoveries and their utilization as tools in translational research, including proof-of-concept, proof-of-mechanism and pharmacodynamics.

Moreover, the speaker will show data from a novel blood RNA stabilization tube that can keep RNA stable for at least 10 days at ambient temperature.

Join Dr. Abdel Halim, PharmD, PhD, CEO/CSO, Wren Laboratories, for the live webinar on Thursday, September 26, 2024, at 12pm EDT (5pm BST/UK).

For more information, or to register for this event, visit Novel Liquid Biopsy Multigene mRNA Gene Expression Assays for Clinical Trials: Accelerating Discovery to CDx Development.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com

For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, https://xtalks.com 

View original content to download multimedia:https://www.prweb.com/releases/novel-liquid-biopsy-ml-multigene-mrna-expression-for-clinical-trials-from-discovery-to-cdx-development-upcoming-webinar-hosted-by-xtalks-302244717.html

SOURCE Xtalks